McCall McPhersonFounder, Modern Thyroid Clinic.

The common misconception of GLP-1 medications in the media

8 Feb 2024 · 1 min

Watch on YouTube

0:33

YouTube monologue by McCall McPherson discussing a recent study that reports tirzepatide (a GLP-1/dual agonist) prevents neurodegeneration via multiple mechanisms. The speaker emphasizes that these medications have benefits well beyond weight loss and are changing long-term health outcomes. The clip is a short commentary urging audiences not to view GLP-1 drugs solely as weight-loss treatments.

Chapters

A new study came out this week that shows tirzepatide, a GLP1, prevents neurodegeneration in multiple different ways. We talk a lot about these meds and their benefits, and I'm not talking about weight loss because y', all, the benefits, they go on and on and on and on. So let's not think about them as simply weight loss medications that people are using or abusing. These drugs are changing people's long term health outcomes over and over and over.